The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 fourth-quarter conference call. My name is Ezra, and I will be your coordinator today. (Operator Instructions) I ...

Thermo Fisher Scientific Chief Executive Marc N. Casper said Tuesday that he had expected "moderating growth" in 2023 as the COVID-19 pandemic wound down and customers became more cautious.

Marc Casper is chairman, president, and CEO of Thermo Fisher Scientific, the world leader in serving science. He leads more than 100,000 colleagues globally to fulfill the company’s mission of ...

Q4 2024 Management View CEO Marc Casper highlighted a strong finish to 2024, with revenue growing 5% year-over-year to $11.4 billion and adjusted EPS up 8% to $6.10. He emphasized market share gains ...

ELIO, Thermo Fisher Scientific is closer to its goal of powering its European sites with 100% renewable energy ...

Marc Casper spoke with Jack Hough, Barron's associate editor, at the World Economic Forum in Davos. By Barrons.com 21:39 ...

Thermo Fisher Scientific (NYSE:TMO) traded higher on Thursday after exceeding Street forecasts with its Q4 2024 financials, even as the Waltham, Massachusetts-based healthcare giant set its 2025 ...

Reports Q4 revenue $11.40B, consensus $11.28B. “We finished 2024 with excellent financial performance, delivering strong growth on the top and ...

Core organic revenue rose 5%. "We are in a great position to deliver excellent performance in 2025," Chief Executive Marc Casper said.

Thermo Fisher Scientific Inc. ( NYSE: TMO) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...